Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study
Clin Infect Dis. 2022 May 30;74(10):1889.
doi: 10.1093/cid/ciac243.
1 Center of Research and Disruption of Infectious Diseases, Department of Infectious Diseases, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark.
2 Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
3 Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.
4 Department of Infectious Diseases, Copenhagen University Hospital, Herlev and Gentofte, Herlev, Denmark.
5 Department of Respiratory Medicine and Infectious Diseases, Copenhagen University Hospital, North Zealand, Denmark.
6 Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
7 Department of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
8 Department of Medicine, Kolding Hospital, Kolding, Denmark.
9 Research Unit for Infectious Diseases, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
10 CHIP, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
11 Department of Medicine, Zealand University Hospital, Roskilde, Denmark.
12 Department of Medicine, Herning Hospital, Herning, Denmark.
13 Department of Clinical Pharmacology, Aalborg University Hospital, Aalborg, Denmark.
14 Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
15 Department of Medicine, Esbjerg Hospital, Esbjerg, Denmarkand.
16 Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.